SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001178913-20-003242
Filing Date
2020-11-24
Accepted
2020-11-24 06:04:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G zk2025196.htm SC 13G 53894
  Complete submission text file 0001178913-20-003242.txt   55365
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 201339808
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 18 YEHEZKEL ST TEL AVIV-YAFO L3 6259524
Business Address
NACHT MARIUS (Filed by) CIK: 0001218503 (see all company filings)

Type: SC 13G